NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
+18.24%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$712M
AUM Growth
+$712M
(+20%)
Cap. Flow
+$21.7M
Cap. Flow
% of AUM
3.04%
Top 10 Holdings %
Top 10 Hldgs %
90.92%
Holding
15
New
2
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$15.8M |
| 2 |
Zymeworks
ZYME
|
$14M |
| 3 |
Mersana Therapeutics
MRSN
|
$4.8M |
Top Sells
| 1 |
ARS Pharmaceuticals
SPRY
|
$11.6M |
| 2 |
Cullinan Oncology
CGEM
|
$1.34M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $286M | 40.09% | 6,296,740 | – | – |
|
2
Tyra Biosciences
TYRA
$675M
| $95.4M | 13.39% | 4,055,861 | – | – |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $54.2M | 7.61% | 5,285,714 | – | – |
|
|
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
| $48.8M | 6.84% | 2,642,502 | – | – |
|
5
Tango Therapeutics
TNGX
$747M
| $42.6M | 5.98% | 5,533,980 | – | – |
|
6
Arvinas
ARVN
$568M
| $34.7M | 4.87% | 1,408,394 | – | – |
|
7
Relay Therapeutics
RLAY
$619M
| $27.2M | 3.82% | 3,846,409 | – | – |
|
|
8
Mersana Therapeutics
MRSN
$36.5M
| $22.8M | 3.2% | 12,067,246 +2,541,100 | +27% | +$4.8M |
|
|
9
Cullinan Oncology
CGEM
$445M
| $19.1M | 2.68% | 1,141,145 -80,000 | -7% | -$1.34M |
|
|
SLN
10
Silence Therapeutics
SLN
$227M
| $17.3M | 2.43% | 952,400 | – | – |
|
|
11
ARS Pharmaceuticals
SPRY
$1.15B
| $16.1M | 2.27% | 1,113,029 -797,000 | -42% | -$11.6M |
|
|
ALMS
12
Alumis Inc. Common Stock
ALMS
$479M
| $15.8M | 2.21% | +1,476,998 | New | +$15.8M |
|
13
Context Therapeutics
CNTX
$75.4M
| $14.5M | 2.04% | 7,419,355 | – | – |
|
|
14
Zymeworks
ZYME
$1.12B
| $14M | 1.96% | +1,113,946 | New | +$14M |
|
|
BOLD
15
Boundless Bio
BOLD
$25.1M
| $4.26M | 0.6% | 1,228,069 | – | – |
|